Nyrada operates in the biotechnology sector, developing therapies or health technologies aimed at addressing unmet medical needs. Biotech companies are typically valued on the potential of their pipeline, the strength of their clinical data, intellectual property, and their pathway towards regulatory approval and commercialisation. …
In the sections that follow, we examine Cochlear's business, the possible reasons COH stock has caught the market's eye, the broader medical devices and healthcare technology context, and the factors ASX investors may keep under review. None of this should be read as financial …
Imugene operates in the biotechnology sector, developing therapies or health technologies aimed at addressing unmet medical needs. Biotech companies are typically valued on the potential of their pipeline, the strength of their clinical data, intellectual property, and their pathway towards regulatory approval and commercialisation. …
Below, we break down the company's core business, the themes that may be driving attention to ARX stock, the state of the medical devices and healthcare technology sector, and the watchpoints that could matter for ASX investors. The aim is to provide balanced context …
Health technology remains one of the most innovative areas of the Australian market, and 4DMedical (ASX:4DX) has become a closely watched name because of its software-based approach to lung imaging. The company aims to provide deeper functional insights from medical scans using software and …
Artrya Limited (ASX:AYA) sits at the intersection of artificial intelligence and healthcare, making it one of the more closely watched health-tech names on the ASX. The company focuses on improving the detection of coronary artery disease through AI-powered analysis of cardiac CT scans.
After a stretch in which high-growth and cyclical stocks soaked up the spotlight, CSL is back into focus, and investors are paying attention. The reason is simple to grasp but powerful in practice. People need plasma therapies, vaccines, and treatments for chronic conditions regardless …
Clinuvel Pharmaceuticals (ASX:CUV) has established itself as one of Australia's prominent biotechnology companies, focusing on treatments for rare disorders and pigmentary diseases. Over the years, the company has built a niche position in photomedicine through its lead therapy, SCENESSE® (afamelanotide), which is approved in …
Pro Medicus Limited (ASX: PME) is a leading healthcare informatics company founded in 1983 and headquartered in Melbourne. The company provides medical imaging software and services to hospitals, imaging centres, and healthcare groups worldwide through its Visage 7 suite of products. The Visage 7 …
4DMedical Limited (ASX:4DX) is a Melbourne-based global respiratory imaging technology company whose core product, CT:VQ, is a software platform designed to measure lung function using conventional CT scanners — without the radiation exposure or logistical complexity associated with traditional nuclear medicine ventilation-perfusion (VQ) scans. …